Membrane fluidization by ether, other anesthetics, and certain agents abolishes P‐glycoprotein ATPase activity and modulates efflux from multidrug‐resistant cells
Open Access
- 1 January 1999
- journal article
- research article
- Published by Wiley in European Journal of Biochemistry
- Vol. 259 (1-2), 18-24
- https://doi.org/10.1046/j.1432-1327.1999.00037.x
Abstract
The anesthetics benzyl alcohol and the nonaromatic chloroform and diethyl ether, abolish P‐glycoprotein (Pgp) ATPase activity in a mode that does not fit classical competitive, noncompetitive, or uncompetitive inhibition. At concentrations similar to those required for inhibition of ATPase activity, these anesthetics fluidize membranes leading to twofold acceleration of doxorubicin flip‐flop across lipid membranes and prevent photoaffinity labeling of Pgp with [125I]‐iodoarylazidoprazosin. Similar concentrations of ether proved nontoxic and modulated efflux from Pgp‐overexpressing cells. A similar twofold acceleration of doxorubicin flip‐flop rate across membranes was observed with neutral mild detergents, including Tween 20, Nonidet P‐40 and Triton X‐100, and certain Pgp modulators, such as verapamil and progesterone. Concentrations of these agents, similar to those required for membrane fluidization, inhibited Pgp ATPase activity in a mode similar to that observed with the anesthetics. The mode of inhibition, i.e. lack of evidence for classical enzyme inhibition and the correlation of Pgp ATPase inhibition with membrane fluidization over a wide range of concentrations and structures of drugs favors the direct inhibition of Pgp ATPase activity by membrane fluidization. The unusual sensitivity of Pgp to membrane fluidization, as opposed to acceleration of ATPase activity of ion transporters, could fit the proposed function of Pgp as a ‘flippase’, which is in close contact with the membrane core.Keywords
This publication has 46 references indexed in Scilit:
- Mutations in Either Nucleotide-Binding Site of P-glycoprotein (Mdr3) Prevent Vanadate Trapping of Nucleotide at Both SitesBiochemistry, 1998
- A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemiaLeukemia, 1997
- Extended multidrug resistance in haemopoietic cellsBritish Journal of Haematology, 1996
- Co-operative, competitive and non-competitive interactions between modulators of P-glycoproteinBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1996
- Transport Studies of Doxorubicin in Model Membranes Indicate a Difference in Passive Diffusion across and Binding at the Outer and Inner Leaflet of the Plasma MembraneBiochemistry, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Multidrug Resistance-Associated Protein: Sequence CorrectionScience, 1993
- P-glycoprotein possesses A 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding siteBiochemical and Biophysical Research Communications, 1992
- The mdrl gene, responsible for multidrug-resistance, codes for P-glycoproteinBiochemical and Biophysical Research Communications, 1986
- The interaction of adriamycin with cardiolipin in model and rat liver mitochondrial membranesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1984